Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@genomics-online.com

Mouse Src CRISPR gRNA + Cas9 in Lenti Particles

This is a Proto-oncogene tyrosine-protein kinase Src plasmid with gRNA + Cas9 insert cloned into Lentiviral VectorpLenti-U6-sgRNA-SFFV-Cas9-2A-Puro. Insert length: not_set. Stable, Transient expression. Suitable for PExp and GEEN. Bacterial selection: Ampicillin.
Catalog No. ABIN5262808
$1,968.75
Plus shipping costs $50.00, if applicable $20.00 dry ice
3 x 300 μL
Shipping to: United States
Delivery in 31 to 42 Business Days

Quick Overview for Mouse Src CRISPR gRNA + Cas9 in Lenti Particles (ABIN5262808)

Gene

Src (Proto-oncogene tyrosine-protein kinase Src (Src))

Application

Protein Expression (PExp), Genome Editing with Engineered Nucleases (GEEN)

Insert

gRNA + Cas9

Vector

Lentiviral Vector

Vector Backbone

pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro

Promoter

U6 Promoter, SFFV Promoter

Bacterial Resistance

Ampicillin

Expression Type

Stable, Transient
  • Species

    Mouse

    Purpose

    Set of 3 gRNA against Src in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (sgRNA and Cas9 in a single vector)

    Sequence

    Sequence available upon placing order

    Specificity

    GRNAs are designed for use with Cas9 Nuclease only.
    Cas9 Nuclease is under the control of the SFFV promoter which should work for a vast majority of cells, except ES cells or iPS cells.

    Components

    Lentiviral particles with a set of 3 gRNAs (3 x 300 μL) covering different sequences of Src

    Selectable Marker

    Puromycin

    Sequencing Primer

    U6 Forward Primer: 5'--TACGTCCAAGGTCGGGCAGGAAGA--3'
  • Application Notes

    Recommended for quality control: Restriction Enzyme Digest and Sequencing

    Restrictions

    For Research Use only
  • Format

    Viral Particles

    Storage

    -80 °C

    Expiry Date

    12 months
  • Target

    Src (Proto-oncogene tyrosine-protein kinase Src (Src))

    Alternative Name

    Src

    Target Type

    Viral Protein

    NCBI Accession

    NM_009271
You are here: